← Open Payments lookup

MANISH SARAN: Open Payments

NPI 1821208224 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,195 in 122 payments from 16 companies in 2025. Trend: 2023 $1,804 · 2024 $2,095 · 2025 $2,195

Food & beverage: $2,195
CompanyPaymentsAmount
Alkermes, Inc.28$479
Neurocrine BioSciences, Inc.25$379
Collegium Pharmaceutical, Inc.10$186
Supernus Pharmaceuticals, Inc.8$186
Teva Pharmaceuticals USA, Inc.8$146
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$133
Lundbeck LLC5$118
E.R. Squibb & Sons, L.L.C.5$101
Takeda Pharmaceuticals U.S.A., Inc.5$91
Vanda Pharmaceuticals Inc.5$84

Products named: INGREZZA, ARISTADA, Jornay PM, Qelbree, LYBALVI, REXULTI, AUSTEDO XR, CAPLYTA.

Industry payments across LA — which companies pay providers there.